<style>
/* ---- 背景 ---- */
body {
  background:
    linear-gradient(rgba(255,255,255,0.60), rgba(255,255,255,0.60)),
    url("car-t-cell-therapy-2x.jpg");
  background-size: cover;
  background-attachment: fixed;
  background-position: center;
  font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", system-ui, sans-serif;
  margin: 0;
  padding: 0;
}

/* ---- 导航栏 ---- */
.navbar {
  text-align: center;
  font-size: 16px;
  margin: 25px 0 10px 0;
}

.navbar a {
  color: #8c1515;  /* Stanford Cardinal */
  text-decoration: none;
  margin: 0 12px;
  font-weight: 500;
}

.navbar a:hover {
  text-decoration: underline;
}

/* ---- 主体容器 ---- */
.lab-container {
  max-width: 900px;
  margin: 35px auto 60px auto;
  padding: 0 15px;
}

/* ---- 区块样式 ---- */
.lab-section {
  background: rgba(255,255,255,0.92);
  border-radius: 12px;
  padding: 22px 26px;
  margin-bottom: 28px;
  box-shadow: 0 6px 20px rgba(0,0,0,0.10);
  border-left: 5px solid #8c1515; /* Stanford Cardinal */
}

/* ---- 标题 ---- */
.lab-section h2 {
  font-size: 22px;
  margin: 0 0 10px 0;
  color: #2c3e50;
  font-weight: 650;
  letter-spacing: -0.3px;
}

/* ---- 正文 ---- */
.lab-section p {
  font-size: 16.5px;
  line-height: 1.75;
  color: #333;
  margin: 0;
}

</style>

<!-- ---- 导航栏 ---- -->
<div class="navbar">
  <a href="/lab">Home</a> ·
  <a href="/lab/members">Members</a> ·
  <a href="/lab/Research">Research</a> ·
  <a href="/lab/publications">Publications</a> ·
  <a href="/lab/contact">Contact</a>
</div>

<hr style="max-width:900px; border:0; border-top:1px solid #ccc; margin-bottom:30px;">

<!-- ---- 内容主体 ---- -->
<div class="lab-container">

  <div class="lab-section">
    <h2>Virus-driven immune remodeling in transplantation and cellular therapies</h2>
    <p>
      We study how CMV, EBV, and other viral exposures reshape immune reconstitution after HSCT, CAR-T therapy, and other advanced cellular treatments. Using longitudinal CyTOF and single-cell sequencing, we map immune trajectories and identify signatures linked to toxicity, relapse, and infection. Computational models integrate viral kinetics with immune dynamics to guide precision monitoring and therapeutic decision-making.
    </p>
  </div>

  <div class="lab-section">
    <h2>Precision immunology and immunotherapy in acute myeloid leukemia</h2>
    <p>
      AML serves as a key disease model to understand therapy-induced immune remodeling. We investigate how induction regimens such as HAV, antigen drift, and the immune microenvironment shape AML outcomes. We also develop and evaluate AML-directed immunotherapies—including CAR-T cells, vaccines, and viral-antigen–driven immunogenic strategies—to enhance antileukemic immunity and improve long-term survival.
    </p>
  </div>

  <div class="lab-section">
    <h2>Integrating HSCT and CAR-T with multimodal immunotherapies</h2>
    <p>
      We integrate HSCT, CAR-T, and additional immune-based approaches to develop multimodal therapeutic strategies aimed at improving long-term disease control in hematologic malignancies.
    </p>
  </div>

</div>
